Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in Diabetic Patients with Stable CAD
NCT02889549Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Aug 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ticagrelor in coronary artery disease (CAD), sponsored by The First Affiliated Hospital of Harbin Medical University. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02889549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889549.